1. Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma
   Ryo Ito et al, 2023, Hepatology International CrossRef
2. Inflammatory response in gastrointestinal cancers: Overview of six transmembrane epithelial antigens of the prostate in pathophysiology and clinical implications
   Ze-Xuan Fang et al, 2024, World Journal of Clinical Oncology CrossRef
3. Proteomic analysis of STEAP1 knockdown in human LNCaP prostate cancer cells
   Sandra M. Rocha et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
4. Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma
   Dong-Min Shi et al, 2023, Cellular Signalling CrossRef
5. Regulatory Roles of Six-Transmembrane Epithelial Antigen of the Prostate Family Members in the Occurrence and Development of Malignant Tumors
   Wen-Jia Chen et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
6. STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
   Sandra M. Rocha et al, 2023, International Journal of Molecular Sciences CrossRef
7. Comprehensive Landscape of STEAP Family Members Expression in Human Cancers: Unraveling the Potential Usefulness in Clinical Practice Using Integrated Bioinformatics Analysis
   Sandra M. Rocha et al, 2022, Data CrossRef
8. Targeting STEAP1 as an anticancer strategy
   Hajime Nakamura et al, 2023, Frontiers in Oncology CrossRef
9. STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide
   Sandra Rocha et al, 2023, Molecular Medicine Reports CrossRef